Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis.

导出 LinkOut

翻译打印收藏纠错

作者： Stanley,Cohen ^[1] ; Jeffrey R,Curtis ^[2] ; Theodore,Mellors ^[3] ; Lixia,Zhang ^[3] ; Johanna B,Withers ^[4] ; Alex,Jones ^[3] ; Susan D,Ghiassian ^[3] ; Viatcheslav R,Akmaev ^[3]

作者单位： Internal Medicine, Rheumatology Division, Metroplex Clinical Research Center, Dallas, TX, USA. ^[1] Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. ^[2] Scipher Medicine Corporation, 221 Crescent St, Suite 103A, Waltham, MA, USA. ^[3] Scipher Medicine Corporation, 221 Crescent St, Suite 103A, Waltham, MA, USA. johanna.withers@scipher.com. ^[4]

关键词 Clinical assessments Molecular signature response classifier Precision medicine Rheumatoid arthritis

DOI 10.1007/s40744-022-00506-0

PMID 36441482

发布时间 2023-09-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Rheumatology and therapy

2023年10卷1期

1-6页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Commentary on Cohen et al.: Role of Clinical Factors in Precision Medicine Test to Predict Nonresponse to TNFi Therapies in Rheumatoid Arthritis.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

检索历史清除